You need to login...
If you are not registered...
| Subscribe to Cancer Stat: | |
|
or call us on: +43 (0)1 71 72 8 900 or email: apus@templetonapus.com |
|
Most viewed
- 1. A Phase IIa Study to Evaluate the Efficacy and Safety of 6MW3211 in Patients With Advanced Lung Cancer
- 2. MilliporeSigma Opens $65M CDMO Facility for Cancer Therapies
- 3. Study shows which patients with advanced prostate cancer will benefit from chemotherapy
- 4. Israeli company to test if fecal bacteria pills boost cancer immunotherapy
- 5. Assessment of Quality of Life After Low Anterior Resection During Cytoreductive Surgery for Advanced Ovarian Cancer
- 6. Canadian Candu produces cancer therapy isotope
- 7. Bristol Myers must face $6.4 billion lawsuit over delayed cancer drug
- 8. Azacitidine in Combination With Low Dose Intensity Venetoclax in Patients With AML Incl. Explorative AML Profiling
- 9. Essex boy, cancer survivor, and now Wimbledon wildcard at 26 - meet Ryan Peniston
- 10. Summary of opinion: Pepaxti,melphalan flufenamide, 23/06/2022, Positive
Last updated at 10:57 GMT
Hot News Makers
Health/Pharma Companies
-
58559.90
-
5991.46
-
3584.93
-
2325.89
-
2195.76
-
1839.07
-
1823.49
-
1421.14
-
1202.08
-
1021.52
Last updated at 10:10 GMT